Vistin Pharma ASA (VP4.F)
- Previous Close
1.9850 - Open
1.9650 - Bid 1.9950 x --
- Ask 2.0500 x --
- Day's Range
1.9650 - 2.1000 - 52 Week Range
1.6950 - 2.3900 - Volume
50 - Avg. Volume
8 - Market Cap (intraday)
93.124M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
17.50 - EPS (TTM)
0.1200 - Earnings Date Apr 25, 2025
- Forward Dividend & Yield 0.11 (5.08%)
- Ex-Dividend Date Jun 4, 2025
- 1y Target Est
--
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
www.vistin.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: VP4.F
View MorePerformance Overview: VP4.F
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VP4.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VP4.F
View MoreValuation Measures
Market Cap
89.21M
Enterprise Value
87.20M
Trailing P/E
17.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.59
Price/Book (mrq)
3.59
Enterprise Value/Revenue
2.42
Enterprise Value/EBITDA
9.15
Financial Highlights
Profitability and Income Statement
Profit Margin
14.61%
Return on Assets (ttm)
13.53%
Return on Equity (ttm)
19.85%
Revenue (ttm)
429.5M
Net Income Avi to Common (ttm)
62.75M
Diluted EPS (ttm)
0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
12.79M
Total Debt/Equity (mrq)
0.71%
Levered Free Cash Flow (ttm)
32.94M